HONG KONG and SAN FRANCISCO,Jan. 7,2025-- Akeso,Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce its participation in the upcoming 43rd Annual J.P. Morgan Healthcar
01-08
HL Heroes Video Revealed with the Slogan "Envision the Future" Showcasing Innovations such as HAECHIE,BEETLE+,and AgriShield
01-08
HONG KONG,Jan. 7,2025-- As Q1 2025 begins,the global economy faces challenges from Trump\'s return,central bank policies,and geopolitical shifts. Following a volatile 2024,Trump\'s pro-business polici
01-08
The latest funding round will fuel Weimai\'s efforts to expand its full-cycle healthcare solutions,leveraging AI and digital tools to provide comprehensive care across China
01-08
Micromobility leader announces verified milestone as it debuts new models during CES 2025 LAS VEGAS,Jan. 7,2025-- Segway,the global leader in micromobility transportation solutions,has been recognized
01-08
SEOUL,South Korea,Jan. 8,2025-- PABLO AIR,a leading company specializing in autonomous swarm control for unmanned aerial vehicles (UAVs),will participate in the world\'s largest electronics exhibition
01-08
Hesai (Nasdaq: HSAI) introduces new AT1440 with the world\'s highest number of channels for an automotive lidar and the FTX solid-state lidar with the world\'s widest field of view
01-08
Enjoying anywhere - Implementing realistic images on dimming Free design - Innovative processing technology for curved lens
01-08
LAS VEGAS,Jan. 8,2025-- Reolink,an innovative leader in intelligent visual technology for the home,today launches the Duo 3 WiFi at CES 2025. It is a 16MP UHD plug-in Wi-Fi camera with expansive 180&
01-08
AT&T is the leading NG911 Service Provider in the United States with direct contracts covering a population of over 80 million and a market share of approximately 30%.
01-08
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
